INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹565 Cr | ₹611 Cr | ₹489 Cr | ₹440 Cr | ₹199 Cr |
What is the latest Total Current Liabilities ratio of INDEGENE ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹565 Cr |
Mar2024 | ₹611 Cr |
Mar2023 | ₹489 Cr |
Mar2022 | ₹440 Cr |
Mar2021 | ₹199 Cr |
How is Total Current Liabilities of INDEGENE Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹565 Cr | -7.60 | |
Mar2024 | ₹611 Cr | 24.90 | |
Mar2023 | ₹489 Cr | 11.05 | |
Mar2022 | ₹440 Cr | 120.85 | |
Mar2021 | ₹199 Cr | - |
Compare Total Current Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,550.0 Cr | -0.7% | -5.7% | 1.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -0.7% |
-5.7% |
1.7% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses